rovalpituzumab tesirine
abbvie
['bet', 'rova,(-approval)', 'rova,(-approval),(-microvascular)', '2019', '2018']
alessandra prezotti at #ash22. metaanalysis. #hemophilia a pup studies. rfviii higher inhibitor rate overall. for high titre inhibitors, only in 2nd generation rfviii had a higher risk. 
Professor of Haemostasis and Thrombosis in Sheffield, UK. I tweet about thrombosis, hemophilia, COVID-19, medicine & NHS. Opinions are my own.